C-reactive protein and copeptin: Prognostic predictors in chronic obstructive pulmonary disease exacerbations

Andreea L. Antonescu-Turcu, Rade Tomic

Research output: Contribution to journalReview articlepeer-review

32 Scopus citations

Abstract

Purpose of review Acute exacerbation of chronic obstructive pulmonary disease (COPD) is a natural event in the course of COPD and remains a major cause of morbidity and mortality associated with this disease. Clinical criteria that define an acute exacerbation are subjective and open for debate. Identifying biomarkers that would be easily measured and followed in patients with acute exacerbation of COPD seems to be highly attractive. The aim of this review is to assess the role of biomarkers, C-reactive protein (CRP) and copeptin, as prognostic predictors in COPD exacerbations. Recent findings Many pulmonary biomarkers have been extensively studied in the recent years. CRP and copeptin have gained particular interest. Recent data suggest that CRP is elevated during an acute exacerbation of COPD but CRP alone is neither sensitive nor specific in predicting clinical severity or outcome. Copeptin increases during acute exacerbation of COPD and may correlate with disease severity. Summary Further studies are needed to determine the role of CRP and copeptin as biomarkers that aid in diagnosis and clinical outcome in acute exacerbation of COPD.

Original languageEnglish (US)
Pages (from-to)120-125
Number of pages6
JournalCurrent Opinion in Pulmonary Medicine
Volume15
Issue number2
DOIs
StatePublished - Mar 1 2009

Keywords

  • Acute exacerbation of chronic obstructive pulmonary disease
  • C-reactive protein
  • Copeptin
  • Systemic inflammation

Fingerprint Dive into the research topics of 'C-reactive protein and copeptin: Prognostic predictors in chronic obstructive pulmonary disease exacerbations'. Together they form a unique fingerprint.

Cite this